Tender detail
Open House discount contracts for the active pharmaceutical ingredient Filgotinib, ATC L04AF04
Summary
The tender concerns open-house model non-exclusive discount contracts for medicines containing the active pharmaceutical ingredient Filgotinib (ATC L04AF04) for the period 01 November 2026 to 31 October 2028, with contracts potentially awarded at any time.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.